Diabetes med Farxiga nabs FDA Priority Review for Chronic Kidney Disease

January 13th 2021

AstraZeneca’s leading diabetes medication could be approved to treat chronic kidney disease for patients with and without type 2 diabetes.

MacroGenics treatment for HER2-positive breast cancer to be available in March

January 12th 2021

New treatment for metastatic HER2-positive breast cancer is called Margenza.

Drugmakers raising prices in 2021 but at lower rate

January 6th 2021

Many pharmaceutical manufacturers are raising prices this year, but at a lower overall rate than in the past couple of years, according to a new analysis.

FDA clears first generic for treatment for severe hypoglycemia

January 4th 2021

Amphastar Pharmaceuticals’ generic version will offer stiff competition to Eli Lilly’s Glucagon Emergency Kit for Low Blood Sugar.

Biosimilar to Rituxan expected to hit market in January

December 22nd 2020

The biosimilar to Rituxan is expected to erode market share of the mainstay cancer drug for Roche.